会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TRIAZINE DERIVATIVES
    • TRIAZINE衍生物
    • WO2007128744A2
    • 2007-11-15
    • PCT/EP2007054239
    • 2007-05-02
    • CIBA SC HOLDING AGEHLIS THOMASBORSOS ELEK
    • EHLIS THOMASBORSOS ELEK
    • C07D251/52A61Q17/04C07D251/70
    • C07D251/52C07D251/70
    • Disclosed are triazine derivatives of formula (1), wherein X 1 is a bivalent radical of formula (1a) -NR 9 -A-NR 9 -; (1b); or (1c) *-O-A-O-* A and A' independently from each other are unsubstituted or substituted, straight-chain or branched C 1 -C 12 alkylene, which is optionally interrupted by C 5 -C 12 cycloalkylene, N, O or S; C 5 -C 12 cycloalkylene; biphenylene; C 6 -C 10 arylene; or C 5 -C 10 arylene-(C 1 -C 12 alkylene); R 1 is a radical of formula (1d); (1e); (1f); (1g); or (1h); R 2 and R 3 independently from each other are hydrogen; C 1 -C 12 alkyl; OR 7 ; NR 7 R 8 ; C 6 -C 10 aryl; X 2 is O, or NH; W 1 is C 1 -C 20 alkyl; or a group Sp-Sil; Sp is a straight-chain or branched saturated or single or multiple unsaturated C 3 -C 12 hydrocarbon; Sil is a silane; an oligosiloxane; or a polysiloxane moiety; and R 4 , R 5 R 6 , R 7 , R 8 and R 9 independently from each other are hydrogen; C 1 -C 12 alkyl; or C 3 -C 12 cycloalkyl.
    • 公开了式(1)的三嗪衍生物,其中X 1是式(1a)的二价基团-NR 9 -A-NR 9 - ; (1B); 或(1c)* -OAO- * A和A'彼此独立地是未取代或取代的直链或支链C 1 -C 12亚烷基,其是 任选被C 5 -C 12亚环烷基,N,O或S中断; ç 5 -C 12 亚环烷基; 联苯; ç 6 -C 10 亚芳基; 或C 5 -C 10亚芳基 - (C 1 -C 12 - 亚烷基); R 1是式(1d)的基团; (1E); (1F); (1G); 或(1h); R 2和R 3彼此独立地是氢; ç 1 -C 12 烷基; OR 7 ; NR 7 - [R 8 ; ç 6 -C 10 芳基; X 2是O或NH; W 1是C 1 -C 20烷基; 或一组Sp-Sil; Sp是直链或支链饱和或单或多不饱和C 3 -C 12烃; 硅是硅烷; 低聚硅氧烷; 或聚硅氧烷部分; 和R 4,R 5 R 6,R 7,R 8和R 8,和 R 9彼此独立地是氢; ç 1 -C 12 烷基; 或C 3 -C 12环烷基。